Upcoming events

People are different and so is their cancer, patients should be treated individually.

Upcoming events

September 15, 2021 at 15:00 (CET)

Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.

Read more

September 23, 2021

CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark

Read more and Register

September 28, 2021

Redeye Medtech & Diagnostics Investor meeting

Read more

September 29, 2021

Mangold Investor Lunch

Read more

October 5, 2021 at 15:00 (CET)

Precision Oncology Webinar: Beyond Biomarkers. Clinical Peers (Dr. John Lindsay Marshall, from Georgetown University Hospital, US and Dr Jesús García-Foncillas, from University Hospital Fundación Jimenez Diaz, Madrid, Spain and Dr. Lars Henrik Jensen, University Hospital Vejle, DK) present the role of the functional test IndiTreat® in personalized oncology to oncologists and 2cureX’s Distributors (promoted on Oncology Convention website, UK. Open participation.

Read more and Register

October 12, 2021 at 13:00 (CET)

Webinar: Strategy Update Seminar (organized by Redeye). Open participation. Details provided later.

Read more

October 21, 2021

Presentation by Henrik Harling (CMO 2cureX) at the 17. National Congress of Digestive Cancers (Viseu, Portugal)

Read more

November 25, 2021

Q3 2021 Interim Report released

View previous reports

February 24, 2022

Year-End Report 2021

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.